Form D · Biotechnology
Virax Biolabs Group Ltd
Lanarkshire, X0 · CIK 0001885827
Offering snapshot reported Dec 18, 2025 · SEC filing
- Reported sold
- $5M Offering amount: $5M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 3, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 18, 2025 | Initial | $5,000,000 | No comparison | 1 | SEC filing |
| Oct 17, 2023 | Initial | $2,150,000 | No comparison | 1 | SEC filing |
| Mar 15, 2023 | Initial | $4,000,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $350K
- Finders' fees
- $0
- Form D file number
- 021-567275
The offering relates to the sale of unregistered warrants to purchase ordinary shares which are exercisable immediately after issuance. The above offering amount does not include the proceeds to be received by the Company upon exercise of such warrants.
The placement agent also received a management fee of $50,000, non-accountable expenses of $35,000, legal expenses of $50,000, and warrants to purchase up to 875,000 ordinary shares.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| H.C. Wainwright & Co., LLC | 375 |
Source: Form D, filed Dec 18, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jason Davis | Executive |
| Yair Erez | Director |
| James Foster | Director, Executive |
| Tomasz George | Executive |
| Nelson Haight | Director |
| Nigel Mc Cracken | Director, Executive |
| Evan Norton | Director |
| Cameron Shaw | Director, Executive |
| Mark Ternouth | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
Bio City Glasgow, Bo'ness Road Newhouse
Lanarkshire, X0, ML1 SUH
Lanarkshire, X0, ML1 SUH